Clinical Trials Logo

Clinical Trial Summary

Study to investigate relative bioavailability of up to five different formulations of AZD5069


Clinical Trial Description

An Open-label, Single Centre Relative Bioavailability Study With an Adaptive Design Comparing up to 5 Solid Oral AZD5069 Formulations After Single Dose Administration to Healthy Volunteers ;


Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Uncontrolled and Persistent Asthma

NCT number NCT01989520
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 1
Start date January 2014
Completion date April 2014